Profile | GDS4284 / 201914_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1460.79 | 79 |
GSM687648 | Patient 402 control | 926.953 | 73 |
GSM687653 | Patient 403 control | 1342.71 | 78 |
GSM687658 | Patient 404 control | 828.881 | 71 |
GSM687663 | Patient 411 control | 1003.19 | 74 |
GSM687668 | Patient 422 control | 1418.45 | 79 |
GSM687673 | Patient 424 control | 1022.35 | 74 |
GSM687678 | Patient 425 control | 1405.64 | 78 |
GSM687683 | Patient 427 control | 1386.49 | 78 |
GSM687688 | Patient 428 control | 1713.1 | 82 |
GSM687695 | Patient 441 control | 738.662 | 70 |
GSM687699 | Patient 443 control | 952.278 | 73 |
GSM687704 | Patient 444 control | 1361.35 | 78 |
GSM687707 | Patient 448 control | 1667.02 | 82 |
GSM687712 | Patient 449 control | 1263.21 | 78 |
GSM687719 | Patient 450 control | 1192.1 | 77 |
GSM687724 | Patient 451 control | 1561.59 | 81 |
GSM687728 | Patient 452 control | 972.414 | 74 |
GSM687646 | Patient 401 treated 24h | 1465.61 | 79 |
GSM687649 | Patient 402 treated 24h | 1127.19 | 75 |
GSM687665 | Patient 411 treated 24h | 809.943 | 70 |
GSM687651 | Patient 402 treated 4 weeks | 1375.15 | 78 |
GSM687667 | Patient 411 treated 4 weeks | 1251.81 | 77 |
GSM687670 | Patient 422 treated 24h | 1359.96 | 78 |
GSM687671 | Patient 422 treated 4 weeks | 1675.25 | 81 |
GSM687654 | Patient 403 treated 24h | 1230.97 | 77 |
GSM687675 | Patient 424 treated 24h | 1452.77 | 79 |
GSM687685 | Patient 427 treated 24h | 1456.85 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 1717.21 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 1290.95 | 77 |
GSM687687 | Patient 427 treated 4 weeks | 1979.55 | 83 |
GSM687692 | Patient 428 treated 4h | 1230.81 | 77 |
GSM687716 | Patient 449 treated 4h | 1216.44 | 77 |
GSM687722 | Patient 450 treated 4h | 908.168 | 72 |
GSM687680 | Patient 425 treated 24h | 1224.47 | 77 |
GSM687690 | Patient 428 treated 24h | 1065.79 | 75 |
GSM687700 | Patient 443 treated 24h | 894.721 | 71 |
GSM687705 | Patient 444 treated 24h | 728.138 | 70 |
GSM687714 | Patient 449 treated 24h | 1342.4 | 79 |
GSM687721 | Patient 450 treated 24h | 890.544 | 72 |
GSM687682 | Patient 425 treated 4 weeks | 1154.5 | 76 |
GSM687694 | Patient 428 treated 4 weeks | 1120.54 | 75 |
GSM687702 | Patient 443 treated 4 weeks | 1119.71 | 75 |
GSM687718 | Patient 449 treated 4 weeks | 1118.28 | 76 |
GSM687723 | Patient 450 treated 4 weeks | 1084.61 | 75 |
GSM687661 | Patient 404 treated 4h | 784.929 | 70 |
GSM687710 | Patient 448 treated 4h | 2055.82 | 84 |
GSM687726 | Patient 451 treated 4h | 1645.38 | 81 |
GSM687730 | Patient 452 treated 4h | 729.072 | 66 |
GSM687660 | Patient 404 treated 24h | 764.047 | 72 |
GSM687697 | Patient 441 treated 24h | 951.187 | 74 |
GSM687709 | Patient 448 treated 24h | 1587.79 | 81 |
GSM687725 | Patient 451 treated 24h | 1235.82 | 77 |
GSM687729 | Patient 452 treated 24h | 1218.17 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 1652.77 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 1420.75 | 79 |